CohBar's Unattributed Round

CohBar raised a round of funding on June 14, 2011.

CohBar is a biotechnology company whose mission is to treat age-related diseases and extend healthy life span through the discovery of novel mitochondrial-derived peptides ("MDPs") and the advancement…

Articles about CohBar's Unattributed Round: